Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs

被引:16
作者
Kawabata, M
Hirao, K
Horikawa, T
Suzuki, K
Motokawa, K
Suzuki, F
Azegami, K
Hiejima, K
机构
[1] Tokyo Med & Dent Univ, Dept Internal Med 1, Bunkyo Ku, Sch Med, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Sch Allied Hlth Sci, Tokyo 1138519, Japan
关键词
class Ic antiarrhythmic drug; proarrhythmia; atrial flutter; exercise; beta-blocking agent; syncope;
D O I
10.1054/jelc.2001.22034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe 2 atrial flutter (AFL) patients with syncope during treatment with class Ic antiarrhythmic drugs. During the syncope, 1:1 atrioventricular (AV) conduction during AFL preceded a wide QRS tachycardia. The class Ic drugs, flecainide and pilsicainide, slowed the atrial rate, resulting in AFL with 1:1 AV conduction, and the width of the QRS complexes became wider during the tachycardia. Syncope was abolished after successful radiofrequency catheter ablation of the AFL. These potential proarrhythmic effects of the class Ic drugs should be taken into account in AFL patients, and concomitant use of beta -blocking agents would be critical to prevent proarrhythmias.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 15 条
[1]  
*CARD ARRH SUPPR T, 1989, NEW ENGL J MED, V82, P1106
[2]   SUPRAVENTRICULAR TACHYCARDIA MIMICKING VENTRICULAR-TACHYCARDIA DURING FLECAINIDE TREATMENT [J].
CRIJNS, HJ ;
VANGELDER, IC ;
LIE, KI .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (17) :1303-1306
[3]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788
[4]   Atrial flutter with 1:1 atrioventricular conduction caused by propafenone [J].
El-Harari, MB ;
Adams, PC .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (10) :1999-2001
[5]  
Falk R. H., 1992, ATRIAL FIBRILLATION, P283
[6]   FLECAINIDE-INDUCED VENTRICULAR-TACHYCARDIA AND FIBRILLATION IN PATIENTS TREATED FOR ATRIAL-FIBRILLATION [J].
FALK, RH .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) :107-111
[7]   POSSIBLE ATRIAL PROARRHYTHMIC EFFECTS OF CLASS-1C ANTIARRHYTHMIC DRUGS [J].
FELD, GK ;
CHEN, PS ;
NICOD, P ;
FLECK, RP ;
MEYER, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (03) :378-383
[8]   Proarrhythmia [J].
Friedman, PL ;
Stevenson, WG .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8A) :50N-56N
[9]   Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation [J].
Huang, DT ;
Monahan, KM ;
Zimetbaum, P ;
Papageorgiou, P ;
Epstein, LM ;
Josephson, ME .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1998, 9 (05) :462-469
[10]   FLECAINIDE IN QUINIDINE-RESISTANT ATRIAL-FIBRILLATION [J].
LECLERCQ, JF ;
CHOUTY, F ;
DENJOY, I ;
COUMEL, P ;
SLAMA, R .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (05) :A62-A65